Status: Recruiting
Evaluation of sFlt-1/PlGF Ratio ,OPG and sEng as Predictive Biomarkers in the Diagnosis and Treatment Evaluation of Preeclampsia
his study investigates the effectiveness of three specific biological markers (biomarkers) in the blood-the sFlt-1/PlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)-to better diagnose and monitor preeclampsia. Preeclampsia is a serious pregnancy complication characterized by high blood pressure and potential organ damage that affects 2-8% of pregnancies worldwide
Participants needed: 120
Trial details
Age: 18-45Biological sex: FemaleType: ObservationalSponsor: Ammar Jassim AbedUpdated: Jan 20, 2026Locations: 1
Eligibility criteria
Pregnant women between 20 and 36 weeks of gestation [+2]
Chronic hypertension [+4]